Atlas Trials

Post-marketing Safety Surveillance of Compound Kuh-seng Injection: a Registry Study

Clinical trial NCT02239237 · COMPLETED

Trial details

NCT number
NCT02239237
Sponsor
Zhong Wang
Status
COMPLETED
Study type
OBSERVATIONAL
Safety SurveillanceAdverse Drug EventsAdverse Drug ReactionsSevere Adverse EventsSevere Adverse Reactions
Start date
2014-09-01
Primary completion
2018-06-01
Enrollment
30283

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.